XML 20 R12.htm IDEA: XBRL DOCUMENT v3.25.2
Intangible Assets, Net
 6 Months Ended
Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, Net
4.
Intangible Assets, Net

At June 30, 2025, intangible assets, net, consisted of the following (in thousands):

 

 

Useful
Life
(Years)

 

Gross
June 30,
2025

 

 

Accumulated
Amortization

 

 

Net
June 30,
2025

 

Indefinite lived assets:

 

 

 

 

 

 

 

 

 

 

 

Trademarks and licenses

 

N/A

 

$

4,050

 

 

$

—

 

 

$

4,050

 

Amortized intangible assets:

 

 

 

 

 

 

 

 

 

 

 

Network relationships

 

10-21

 

 

171,917

 

 

 

(118,875

)

 

 

53,042

 

Member relationships

 

7-14

 

 

73,077

 

 

 

(29,373

)

 

 

43,704

 

Other(1)

 

5-20

 

 

26,010

 

 

 

(21,069

)

 

 

4,941

 

 

 

 

$

275,054

 

 

$

(169,317

)

 

$

105,737

 
(1)
Other consists of management contracts, a patient management platform, trade name/trademarks, and developed technology.

 

At December 31, 2024, intangible assets, net, consisted of the following (in thousands):

 

 

Useful
Life
(Years)

 

Gross
December 31,
2024

 

 

Accumulated
Amortization

 

 

Net
December 31,
2024

 

Indefinite lived assets:

 

 

 

 

 

 

 

 

 

 

 

Trademarks and licenses

 

N/A

 

$

4,050

 

 

$

—

 

 

$

4,050

 

Amortized intangible assets:

 

 

 

 

 

 

 

 

 

 

 

Network relationships

 

10-21

 

 

171,917

 

 

 

(114,046

)

 

 

57,871

 

Member relationships

 

7-14

 

 

73,077

 

 

 

(22,406

)

 

 

50,671

 

Other(1)

 

5-20

 

 

26,010

 

 

 

(20,423

)

 

 

5,587

 

 

 

 

$

275,054

 

 

$

(156,875

)

 

$

118,179

 
(1)
Other consists of management contracts, a patient management platform, trade name/trademarks, and developed technology.

 

For the three months ended June 30, 2025 and 2024, the Company recognized amortization expense of $6.2 million and $6.9 million, respectively, in depreciation and amortization in the accompanying condensed consolidated statements of income. For the six months ended June 30, 2025 and 2024, the Company recognized amortization expense of $12.4 million and $11.3 million, respectively, in depreciation and amortization in the accompanying condensed consolidated statements of income. The Company determined that there was no impairment of its finite-lived intangible or long-lived assets during the six months ended June 30, 2025 and 2024.

Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):

 

 

 

Amount

 

2025 (excluding the six months ended June 30, 2025)

 

$

12,215

 

2026

 

 

20,295

 

2027

 

 

16,808

 

2028

 

 

14,077

 

2029

 

 

11,397

 

Thereafter

 

 

26,895

 

 

 

 

 

Total

 

$

101,687